PPARγ ligands have been reported to ameliorate MI through anti-inflammatory effects [161,162,163], and cardiomyocyte-specific PPARγ deletion results in extensive myocardial damage, characterized by increased ventricular dilation, neutrophil infiltration, and elevated proinflammatory cytokine concentrations [164]. The gene discussed is PPARG; the disease is myocardial infarction.